P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT
O. Albanyan,
D. Kalos,
J. Kim,
R. Faramand,
H. Elmariah,
A. Mishra,
T. Nishihori,
L. Perez,
M. Nieder,
J. Pidala,
N. Bejnayan
Affiliations
O. Albanyan
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
D. Kalos
2 Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, United States of America
J. Kim
2 Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, United States of America
R. Faramand
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
H. Elmariah
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
A. Mishra
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
T. Nishihori
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
L. Perez
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
M. Nieder
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
J. Pidala
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
N. Bejnayan
1 Department of Blood and Marrow Transplantation – Cellular Immunotherapy
